Lakefront Biotherapeutics NV (LKFT)

NASDAQ: LKFT · Real-Time Price · USD

28.80

+0.53 (1.87%)

At close: Aug 21, 2026, 4:00 PM EDT

28.78

-0.02 (-0.07%)

After-hours: Aug 21, 2026, 7:30 PM EDT

LKFT Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	135.95	87.87	64.24	166.8	508.12	2,233
Short-Term Investments	2,104	2,910	3,053	3,518	3,586	2,470
Cash & Short-Term Investments	2,240	2,998	3,118	3,685	4,094	4,703
Cash Growth	-27.56%	-3.83%	-15.39%	-10.00%	-12.95%	-8.88%
Accounts Receivable	23.7	9.57	32.47	17.49	28.19	91.79
Other Receivables	32.6	43.64	55.62	48.16	49.15	36.82
Receivables	56.3	53.2	88.09	65.66	77.34	128.6
Inventory	8.54	22.49	51.19	73.98	52.93	20.57
Prepaid Expenses	-	0.1	0.1	0.74	0.49	0.2
Other Current Assets	4.97	5.61	82.49	36.72	12.03	9.31
Total Current Assets	2,309	3,079	3,339	3,862	4,237	4,862
Property, Plant & Equipment	76.89	80.66	122.9	126.32	154.25	137.51
Long-Term Investments	73.86	46.81	253.12	13.58	-	-
Goodwill	-	-	70.01	69.56	69.81	-
Other Intangible Assets	750.66	0.85	157.68	119.19	136.1	48.31
Long-Term Deferred Tax Assets	0.13	0.2	1.47	1.13	1.36	4.03
Long-Term Deferred Charges	-	-	7.18	8.72	10.26	11.8
Other Long-Term Assets	140.23	177.37	183.9	157.32	125.72	129.66
Total Assets	3,351	3,407	4,136	4,357	4,734	5,193

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	66.35	32.62	64.23	134.65	133.3	134.3
Accrued Expenses	-	0.02	1.09	0.55	0.65	3.11
Current Portion of Leases	1.59	1.73	3.48	4.65	7.21	7.2
Current Income Taxes Payable	0.95	0.96	0.25	0.06	1.02	1.78
Current Unearned Revenue	0.03	0.03	232.48	256.27	365.63	419.87
Other Current Liabilities	1.4	117.51	33.56	32.04	14.73	0.2
Total Current Liabilities	70.32	152.86	335.08	428.22	522.54	566.47
Long-Term Leases	4.77	5.19	8.24	4.94	14.69	19.66
Long-Term Unearned Revenue	-	-	838.88	1,071	1,624	1,945
Pension & Post-Retirement Benefits	-	-	2.1	2.29	5.54	11.7
Long-Term Deferred Tax Liabilities	-	-	20.66	23.61	20.15	-
Other Long-Term Liabilities	12.46	12.6	33.82	31.57	21.81	7.13
Total Liabilities	87.56	170.65	1,239	1,562	2,208	2,550

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	293.94	293.94	356.44	356.44	356.11	354.58
Additional Paid-In Capital	2,737	2,737	2,737	2,737	2,736	2,730
Retained Earnings	233.96	210.58	-134.31	-228.27	-496.69	-367.21
Comprehensive Income & Other	4.82	-5.64	-62.19	-69.6	-68.95	-74.41
Shareholders' Equity	3,264	3,236	2,897	2,796	2,526	2,643
Total Liabilities & Equity	3,351	3,407	4,136	4,357	4,734	5,193

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	6.36	6.92	11.72	9.6	21.9	26.86
Net Cash (Debt)	2,233	2,991	3,106	3,675	4,072	4,676
Net Cash Growth	-27.57%	-3.69%	-15.48%	-9.75%	-12.92%	-8.88%
Net Cash Per Share	33.87	45.39	47.10	55.74	61.98	71.39
Filing Date Shares Outstanding	65.66	65.9	65.9	65.9	65.84	65.65
Total Common Shares Outstanding	65.66	65.9	65.9	65.9	65.84	65.55
Working Capital	2,239	2,927	3,004	3,433	3,714	4,295
Book Value Per Share	49.71	49.10	43.96	42.42	38.37	40.32
Tangible Book Value	2,513	3,235	2,669	2,607	2,320	2,595
Tangible Book Value Per Share	38.28	49.09	40.51	39.56	35.24	39.59
Land	-	84.99	86.01	90.71	88.72	26.13
Machinery	-	37.92	56.75	49.03	67.28	54.1

SEC Filings: 10-K · 10-Q